The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albumin (Human) Market Research Report 2025
Synopsis
The global Albumin (Human) market was valued at US$ 5132.1 million in 2023 and is anticipated to reach US$ 6954 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Albumin (Human) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Albumin (Human) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Albumin (Human) include CSL Behring, Baxter, Grifols, Octapharma, Zhongsheng Group, Taibang Bio, Shanghai Laishi and Hualan Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Albumin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (Human).
Report Scope
The Albumin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albumin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Baxter
Grifols
Octapharma
Zhongsheng Group
Taibang Bio
Shanghai Laishi
Hualan Bio
Segment by Type
Injection
Freeze-dried Injection
Segment by Application
Liver Diseases
Kidney Diseases
Neoplasm
Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Albumin (Human) market was valued at US$ 5132.1 million in 2023 and is anticipated to reach US$ 6954 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
North American market for Albumin (Human) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Albumin (Human) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Albumin (Human) include CSL Behring, Baxter, Grifols, Octapharma, Zhongsheng Group, Taibang Bio, Shanghai Laishi and Hualan Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Albumin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (Human).
Report Scope
The Albumin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albumin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Baxter
Grifols
Octapharma
Zhongsheng Group
Taibang Bio
Shanghai Laishi
Hualan Bio
Segment by Type
Injection
Freeze-dried Injection
Segment by Application
Liver Diseases
Kidney Diseases
Neoplasm
Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albumin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albumin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albumin (Human) Market Overview
1.1 Product Overview and Scope of Albumin (Human)
1.2 Albumin (Human) Segment by Type
1.2.1 Global Albumin (Human) Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-dried Injection
1.3 Albumin (Human) Segment by Application
1.3.1 Global Albumin (Human) Market Value by Application: (2024-2030)
1.3.2 Liver Diseases
1.3.3 Kidney Diseases
1.3.4 Neoplasm
1.3.5 Other Diseases
1.4 Global Albumin (Human) Market Size Estimates and Forecasts
1.4.1 Global Albumin (Human) Revenue 2019-2030
1.4.2 Global Albumin (Human) Sales 2019-2030
1.4.3 Global Albumin (Human) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Albumin (Human) Market Competition by Manufacturers
2.1 Global Albumin (Human) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Albumin (Human) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Albumin (Human) Average Price by Manufacturers (2019-2024)
2.4 Global Albumin (Human) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albumin (Human), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albumin (Human), Product Type & Application
2.7 Albumin (Human) Market Competitive Situation and Trends
2.7.1 Albumin (Human) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Albumin (Human) Players Market Share by Revenue
2.7.3 Global Albumin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albumin (Human) Retrospective Market Scenario by Region
3.1 Global Albumin (Human) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Albumin (Human) Global Albumin (Human) Sales by Region: 2019-2030
3.2.1 Global Albumin (Human) Sales by Region: 2019-2024
3.2.2 Global Albumin (Human) Sales by Region: 2025-2030
3.3 Global Albumin (Human) Global Albumin (Human) Revenue by Region: 2019-2030
3.3.1 Global Albumin (Human) Revenue by Region: 2019-2024
3.3.2 Global Albumin (Human) Revenue by Region: 2025-2030
3.4 North America Albumin (Human) Market Facts & Figures by Country
3.4.1 North America Albumin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Albumin (Human) Sales by Country (2019-2030)
3.4.3 North America Albumin (Human) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albumin (Human) Market Facts & Figures by Country
3.5.1 Europe Albumin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Albumin (Human) Sales by Country (2019-2030)
3.5.3 Europe Albumin (Human) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albumin (Human) Market Facts & Figures by Country
3.6.1 Asia Pacific Albumin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Albumin (Human) Sales by Country (2019-2030)
3.6.3 Asia Pacific Albumin (Human) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Albumin (Human) Market Facts & Figures by Country
3.7.1 Latin America Albumin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Albumin (Human) Sales by Country (2019-2030)
3.7.3 Latin America Albumin (Human) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albumin (Human) Market Facts & Figures by Country
3.8.1 Middle East and Africa Albumin (Human) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Albumin (Human) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Albumin (Human) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Albumin (Human) Sales by Type (2019-2030)
4.1.1 Global Albumin (Human) Sales by Type (2019-2024)
4.1.2 Global Albumin (Human) Sales by Type (2025-2030)
4.1.3 Global Albumin (Human) Sales Market Share by Type (2019-2030)
4.2 Global Albumin (Human) Revenue by Type (2019-2030)
4.2.1 Global Albumin (Human) Revenue by Type (2019-2024)
4.2.2 Global Albumin (Human) Revenue by Type (2025-2030)
4.2.3 Global Albumin (Human) Revenue Market Share by Type (2019-2030)
4.3 Global Albumin (Human) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Albumin (Human) Sales by Application (2019-2030)
5.1.1 Global Albumin (Human) Sales by Application (2019-2024)
5.1.2 Global Albumin (Human) Sales by Application (2025-2030)
5.1.3 Global Albumin (Human) Sales Market Share by Application (2019-2030)
5.2 Global Albumin (Human) Revenue by Application (2019-2030)
5.2.1 Global Albumin (Human) Revenue by Application (2019-2024)
5.2.2 Global Albumin (Human) Revenue by Application (2025-2030)
5.2.3 Global Albumin (Human) Revenue Market Share by Application (2019-2030)
5.3 Global Albumin (Human) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Albumin (Human) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Albumin (Human) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Albumin (Human) Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Albumin (Human) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Zhongsheng Group
6.5.1 Zhongsheng Group Corporation Information
6.5.2 Zhongsheng Group Description and Business Overview
6.5.3 Zhongsheng Group Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhongsheng Group Albumin (Human) Product Portfolio
6.5.5 Zhongsheng Group Recent Developments/Updates
6.6 Taibang Bio
6.6.1 Taibang Bio Corporation Information
6.6.2 Taibang Bio Description and Business Overview
6.6.3 Taibang Bio Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taibang Bio Albumin (Human) Product Portfolio
6.6.5 Taibang Bio Recent Developments/Updates
6.7 Shanghai Laishi
6.6.1 Shanghai Laishi Corporation Information
6.6.2 Shanghai Laishi Description and Business Overview
6.6.3 Shanghai Laishi Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Laishi Albumin (Human) Product Portfolio
6.7.5 Shanghai Laishi Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Corporation Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Albumin (Human) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hualan Bio Albumin (Human) Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albumin (Human) Industry Chain Analysis
7.2 Albumin (Human) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albumin (Human) Production Mode & Process
7.4 Albumin (Human) Sales and Marketing
7.4.1 Albumin (Human) Sales Channels
7.4.2 Albumin (Human) Distributors
7.5 Albumin (Human) Customers
8 Albumin (Human) Market Dynamics
8.1 Albumin (Human) Industry Trends
8.2 Albumin (Human) Market Drivers
8.3 Albumin (Human) Market Challenges
8.4 Albumin (Human) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albumin (Human) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Albumin (Human) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Albumin (Human) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Albumin (Human) Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Albumin (Human) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Albumin (Human) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Albumin (Human) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Albumin (Human) Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Albumin (Human), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Albumin (Human), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Albumin (Human), Product Type & Application
Table 12. Global Key Manufacturers of Albumin (Human), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albumin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (Human) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Albumin (Human) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Albumin (Human) Sales by Region (2019-2024) & (K Dose)
Table 18. Global Albumin (Human) Sales Market Share by Region (2019-2024)
Table 19. Global Albumin (Human) Sales by Region (2025-2030) & (K Dose)
Table 20. Global Albumin (Human) Sales Market Share by Region (2025-2030)
Table 21. Global Albumin (Human) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Albumin (Human) Revenue Market Share by Region (2019-2024)
Table 23. Global Albumin (Human) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Albumin (Human) Revenue Market Share by Region (2025-2030)
Table 25. North America Albumin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Albumin (Human) Sales by Country (2019-2024) & (K Dose)
Table 27. North America Albumin (Human) Sales by Country (2025-2030) & (K Dose)
Table 28. North America Albumin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Albumin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Albumin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Albumin (Human) Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Albumin (Human) Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Albumin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Albumin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Albumin (Human) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Albumin (Human) Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Albumin (Human) Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Albumin (Human) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Albumin (Human) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Albumin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Albumin (Human) Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Albumin (Human) Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Albumin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Albumin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Albumin (Human) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Albumin (Human) Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East & Africa Albumin (Human) Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East & Africa Albumin (Human) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Albumin (Human) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Albumin (Human) Sales (K Dose) by Type (2019-2024)
Table 51. Global Albumin (Human) Sales (K Dose) by Type (2025-2030)
Table 52. Global Albumin (Human) Sales Market Share by Type (2019-2024)
Table 53. Global Albumin (Human) Sales Market Share by Type (2025-2030)
Table 54. Global Albumin (Human) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Albumin (Human) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Albumin (Human) Revenue Market Share by Type (2019-2024)
Table 57. Global Albumin (Human) Revenue Market Share by Type (2025-2030)
Table 58. Global Albumin (Human) Price (USD/Dose) by Type (2019-2024)
Table 59. Global Albumin (Human) Price (USD/Dose) by Type (2025-2030)
Table 60. Global Albumin (Human) Sales (K Dose) by Application (2019-2024)
Table 61. Global Albumin (Human) Sales (K Dose) by Application (2025-2030)
Table 62. Global Albumin (Human) Sales Market Share by Application (2019-2024)
Table 63. Global Albumin (Human) Sales Market Share by Application (2025-2030)
Table 64. Global Albumin (Human) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Albumin (Human) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Albumin (Human) Revenue Market Share by Application (2019-2024)
Table 67. Global Albumin (Human) Revenue Market Share by Application (2025-2030)
Table 68. Global Albumin (Human) Price (USD/Dose) by Application (2019-2024)
Table 69. Global Albumin (Human) Price (USD/Dose) by Application (2025-2030)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. CSL Behring Albumin (Human) Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Baxter Albumin (Human) Product
Table 79. Baxter Recent Developments/Updates
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Grifols Albumin (Human) Product
Table 84. Grifols Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Octapharma Albumin (Human) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Zhongsheng Group Corporation Information
Table 91. Zhongsheng Group Description and Business Overview
Table 92. Zhongsheng Group Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Zhongsheng Group Albumin (Human) Product
Table 94. Zhongsheng Group Recent Developments/Updates
Table 95. Taibang Bio Corporation Information
Table 96. Taibang Bio Description and Business Overview
Table 97. Taibang Bio Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Taibang Bio Albumin (Human) Product
Table 99. Taibang Bio Recent Developments/Updates
Table 100. Shanghai Laishi Corporation Information
Table 101. Shanghai Laishi Description and Business Overview
Table 102. Shanghai Laishi Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Shanghai Laishi Albumin (Human) Product
Table 104. Shanghai Laishi Recent Developments/Updates
Table 105. Hualan Bio Corporation Information
Table 106. Hualan Bio Description and Business Overview
Table 107. Hualan Bio Albumin (Human) Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Hualan Bio Albumin (Human) Product
Table 109. Hualan Bio Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Albumin (Human) Distributors List
Table 113. Albumin (Human) Customers List
Table 114. Albumin (Human) Market Trends
Table 115. Albumin (Human) Market Drivers
Table 116. Albumin (Human) Market Challenges
Table 117. Albumin (Human) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albumin (Human)
Figure 2. Global Albumin (Human) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Albumin (Human) Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Freeze-dried Injection Product Picture
Figure 6. Global Albumin (Human) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Albumin (Human) Market Share by Application in 2023 & 2030
Figure 8. Liver Diseases
Figure 9. Kidney Diseases
Figure 10. Neoplasm
Figure 11. Other Diseases
Figure 12. Global Albumin (Human) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Albumin (Human) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Albumin (Human) Sales (2019-2030) & (K Dose)
Figure 15. Global Albumin (Human) Average Price (USD/Dose) & (2019-2030)
Figure 16. Albumin (Human) Report Years Considered
Figure 17. Albumin (Human) Sales Share by Manufacturers in 2023
Figure 18. Global Albumin (Human) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Albumin (Human) Players: Market Share by Revenue in 2023
Figure 20. Albumin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Albumin (Human) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Albumin (Human) Sales Market Share by Country (2019-2030)
Figure 23. North America Albumin (Human) Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Albumin (Human) Sales Market Share by Country (2019-2030)
Figure 27. Europe Albumin (Human) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Albumin (Human) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Albumin (Human) Revenue Market Share by Region (2019-2030)
Figure 35. China Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Albumin (Human) Sales Market Share by Country (2019-2030)
Figure 46. Latin America Albumin (Human) Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Albumin (Human) Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Albumin (Human) Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Albumin (Human) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Albumin (Human) by Type (2019-2030)
Figure 56. Global Revenue Market Share of Albumin (Human) by Type (2019-2030)
Figure 57. Global Albumin (Human) Price (USD/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Albumin (Human) by Application (2019-2030)
Figure 59. Global Revenue Market Share of Albumin (Human) by Application (2019-2030)
Figure 60. Global Albumin (Human) Price (USD/Dose) by Application (2019-2030)
Figure 61. Albumin (Human) Value Chain
Figure 62. Albumin (Human) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
